U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07513441) titled 'A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)' on March 31.
Brief Summary: The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Parkinson Disease
Intervention:
DRUG: Lu AF28996
Capsule administered orally per schedule specified in the arm description.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: H. Lundbeck A/S
Published by HT Digital Content Services with permission from Health Daily Digest....